Here's How Stellantis Is in Even Worse Shape Than Its Rival -- but Clear Upside Remains

Stellantis posted $7.4 billion in warranty claims in 2025, equal to about 4.4% of revenue and roughly double the industry norm of 2% to 3%. The company logged the second-highest U.S. recall total last year at 53, but its recall burden is smaller than Ford's 153 while being more costly per event. Management is banking on a $70 billion turnaround plan, including 11 all-new North American vehicles by 2030 and a 35% regional sales-volume increase, but near-term quality and warranty costs remain a material headwind.

Analysis

Stellantis is the cleaner short here, but not because recalls are headline-grabbing; it’s because warranty drag is a margin tax that compounds into product-cycle underperformance. The second-order issue is working capital and dealer behavior: elevated post-sale quality issues force more inventory buffers, more dealer friction, and slower consumer repurchase rates, which can suppress North American mix just as the company needs its new launches to re-rate the equity. GM looks relatively insulated because quality costs are now moving in the right direction, while Ford’s recall burden is less damaging because software fixes are cheap and preserve cash.

The market is likely underappreciating the asymmetry between “recall count” and “economic damage.” If Stellantis can reduce warranty expense by even 100-150 bps of revenue over the next 12-18 months, the earnings leverage could be meaningful; but if quality issues persist through the next launch cycle, the turnaround gets pushed out and the stock remains a value trap. The key risk is timing: product launches take years, but warranty accrual surprises can hit quarterly results immediately, so downside can reprice faster than any operational recovery.

The contrarian setup is that sentiment may already be depressed enough that the stock doesn’t need perfection, only stabilization. That said, the bar for a durable re-rating is higher than simple portfolio reshuffling — investors need evidence that the new North America pipeline is reducing claim frequency, not just adding volume. Until then, the path of least resistance is to favor the company with improving unit economics and avoid the one where every new model launch is carrying a hidden remediation bill.

Key Decisions for Investors

• Short STLA on strength for a 3-6 month horizon; use a rally tied to turnaround headlines as entry, with the thesis that warranty expense revisions will continue to cap multiple expansion.
• Pair trade: long GM / short STLA over 6-12 months. GM has better downside protection if auto demand slows because its earnings quality is improving, while STLA remains exposed to launch execution risk and margin leakage.
• Avoid initiating fresh long F positions until recall-related cash costs normalize for at least 2 consecutive quarters; the stock can work, but the risk/reward is less attractive than GM given the still-elevated quality overhang.
• For aggressive accounts, buy medium-dated STLA puts or put spreads into the next earnings cycle; the best asymmetry is a guide-down driven by warranty accruals rather than a macro demand shock.